Ph.D., Co-Founder and Vice President, Forge Biologics
Biography
Dr. De Silva is an experienced scientist and entrepreneur, with more than a decade of experience in discovery research, therapeutic development, and partnering across oncology, infectious disease, and gene therapy. Prior to founding Forge, she held R&D and leadership roles in both academic and industry settings, including at Genentech, Ohio State University and Myonexus Therapeutics.
Session Abstract – PMWC 2022 Silicon Valley
Track Chair:
Jane Grogan, Graphite Bio
Sessions:
- Building Future Precision Care in Qatar
Session Chair: Khalid Fakhro, Sidra Medicine
- Barbro Friden, Sidra Medicine
- Ziyad Hijazi, Sidra Medicine
- Edison Liu, Jackson Labs - Advances in Gene & Cell Therapies
- Peter Nell, Mammoth
- Laura Sepp-Lorenzino, Intellia Tx
- Amy Simon, Beam Therapeutics
- Eric Ostertag, Poseida Therapuetics
- Jane Grogan, Graphite Bio - Translating CGT to the Clinic
Session Chair: Nicole K. Paulk, UCSF
- Matthew Porteus, Stanford
- Eric Crombez, Ultragenyx Gene Therapy
- Peter Francis, 4D Molecular Therapeutics
- Erandi De Silva, Forge Biologics
- Patrice Hugo, Q2 Solutions - Bioethics & Ethical Implications in Cell and Gene Therapies
Session Chair: Ilana Yurkiewicz, Stanford University
- Past, Present and Future of CRISPR Where will CRISPR Take Us and How is the Technology Evolving to Realize its Full Potential
Session Chair: Janice Chen, Mammoth
- Fyodor Urnov, UC Berkeley
- Kiana Aran, Cardea Bio
- Laura Sepp-Lorenzino, Intellia Tx
